Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Global Parkinson’s Drug Market & Clinical Trial Insight 2025” clinical trials has been added to ResearchAndMarkets.com’s offering. Report…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
DUBLIN–(BUSINESS WIRE)–The “NAD Dependent Protein Deacetylase Sirtuin 1 – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s…
DUBLIN–(BUSINESS WIRE)–The “Tumor Necrosis Factor Receptor Superfamily Member 10B – Pipeline Review, H2 2019” drug pipelines has been added to…
Highly experienced pharmaceutical and biotech professional joins Avacta’s Board CAMBRIDGE, England–(BUSINESS WIRE)–Avacta Group plc (AIM: AVCT), the developer of Affimer®…
SAN DIEGO–(BUSINESS WIRE)–#biotech–Calidi Biotherapeutics, Inc., a clinical‐stage immuno-oncology company at the forefront of cell-based oncolytic virus immunotherapies for cancer, today…
DUBLIN–(BUSINESS WIRE)–The “5-Hydroxytryptamine Receptor 2B – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary 5-Hydroxytryptamine…
DUBLIN–(BUSINESS WIRE)–The “Orexin Receptor Type 2 – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary…
PhoreMost’s next-generation phenotypic screening platform, SITESEEKER, to identify novel targets for Otsuka’s therapeutics discovery programmes Programmes to initially focus on…
University of Genoa Team Presented Strong EyeArt Results at the Macula in Liguria 2020 Conference LOS ANGELES–(BUSINESS WIRE)–#ai4healthcare—Eyenuk Inc., a…